January 2013 - Page 16 of 17

ThursdayJan 03, 2013 7:34 am

Ashley Keller Joins Vringo, Inc. (VRNG) Board of Directors

Yesterday, mobile technologies and intellectual properties developer Vringo announced that Mr. Ashley Keller has joined the company’s Board of Directors. He will serve on the Audit and Compensation Committees of the Board of Directors. Mr. Keller is currently a special situations analyst at Alyeska Investment Group, a multi-strategy hedge fund based in Chicago, where he focuses on investments in companies involved in complex and high-stakes commercial litigation and regulatory matters. “I am honored to join the Vringo board of directors. Thanks to the execution of the company’s exceptional management team, Vringo is an emerging leader in innovating, licensing and protecting…

ThursdayJan 03, 2013 7:33 am

Cardium Therapeutics, Inc. (CXM) to Increase Excellagen Clinical Adoption by U.S. Government Medical Providers via New Distribution Agreement

Today before the opening bell, Cardium Therapeutics announced it has entered a distribution agreement with Academy Medical, LLC to market, sell, and distribute Excellagen to U.S. government medical providers, including the Veterans Administration (VA) healthcare system and military hospitals. An FDA-cleared gel, Excellagen is used to support advanced wound care in a broad range of dermal wounds. Academy Medical’s will initially focus on providing education and training on the use of Excellagen in the treatment of traumatic wounds, non-healing venous, pressure and diabetic ulcers, limb salvage, and post-Mohs skin cancer surgery, while supporting distribution within its growing customer base of…

ThursdayJan 03, 2013 7:33 am

International Stem Cell Corp. (ISCO) Scheduled to Present at the Biotech Showcase 2013 Conference

International Stem Cell Corp., a biotechnology company specializing in the therapeutic applications of human parthenogenetic stem cells (hpSCs) and the development and commercialization of cell-based research and cosmetic products, today announced that Executive Vice President, Dr. Simon Craw, will be presenting at the Biotech Showcase™ 2013 conference early next week. The event is being held in San Francisco at the Parc 55 Wyndham Union Square Hotel. Presentation Details Date: Monday, January 7, 2013 Time: 9:30 pm PST Location: Parc 55 Wyndham Union Square Hotel, San Francisco, CA Room: Room Mission II – Track C Those who wish to attend the…

WednesdayJan 02, 2013 2:57 pm

Innovation Marketing Names AVT, Inc. (AVTC) a Leading Force

Innovation Marketing formally recognized AVT as a leading force behind one of the three biggest trends that Innovation has forecast for 2013 in a report titled “3 Vital Trends of 2013.” ATV is focused on developing automated and self-service retail systems, such as the LCD iVend Stores, AR Walls, and other self-service kiosks and high-end vending machines. ATV claims that their automated retail solutions drive traffic, increases sales, improves security, and lower overhead. In the report, Innovation states that evolving technology and component design will see retail moving more steadily towards automation. Driving these efforts will be attention-getting features such…

WednesdayJan 02, 2013 2:56 pm

Soligenix, Inc. (SNGX) Receives Orphan Drug Designation for OrbeShield™

The U.S. FDA’s Office of Orphan Products Development has granted orphan drug designation to Soligenix Inc.’s OrbeShield™ (oral BDP) as a measure to prevent death following a potentially lethal dose of total body irradiation during or after a radiation disaster. Oral BDP, a highly potent, topically active corticosteroid, is the active ingredient in OrbeShield™, which is currently being developed for the treatment of gastrointestinal acute radiation syndrome (GI ARS), a leading cause of mortality following high doses of total body irradiation (TBI). Orphan drug designation provides a seven-year term of market exclusivity for oral BDP upon final FDA approval, and…

WednesdayJan 02, 2013 2:55 pm

Dejour Energy Inc. (DEJ) Secures $6.5M Deal with Local Drilling Fund to Develop Massive Potential at Kokopelli Field in Colorado

Dejour Energy, the domestic oil and gas developer focused on their sizeable holdings in the Rocky Mountains (some 130k net acres across multiple projects in the Piceance, Uinta, and Paradox Basins of Utah and Colorado), as well as their acreage up in the Alberta/BC region (11k net acres in the Peace River Arch projects), reported today that the company has entered into an agreement valued at $6.5M with a private, Denver-based drilling fund to help complete the first well, in addition to the drilling/completion of three more wells by early 2013, at their 2.2k-acre Kokopelli field development project in northwestern…

WednesdayJan 02, 2013 2:55 pm

GlobalWise Investments, Inc. (GWIV) and Cloud Disaster Recovery

It has been estimated that the global cloud computing industry could be worth nearly a quarter of a trillion dollars by the end of the current decade, with cloud storage playing a major role in that growth. The overall benefits of cloud storage and processing are increasingly well known: Cloud computing reduces up-front investment in hardware and software; it provides flexible levels of storage and service as your business requirements change; it offers tremendous flexibility for data access, especially important for companies with scattered facilities and mobile employees. However, for small businesses that have yet to tap into the cloud,…

WednesdayJan 02, 2013 2:54 pm

Loans4Less.com, Inc. (LFLS) Tracks Your Rate for You

Home mortgage rates have been at historic lows, which is good news for prospective home buyers as well as homeowners considering refinancing. Contemplate this: Even a one point drop in mortgage rate on a 30-year loan for an average home could easily result in a total savings of nearly $40,000 over the full course of the loan. But many variables go into making a refinance decision, and it’s not right for everyone. Nor is it wise to refinance too many times, since hefty up-front charges may eliminate the benefit from lower rates. There are many reasons people may consider a…

WednesdayJan 02, 2013 10:45 am

International Stem Cell Corp. (ISCO) Video Chart for Wednesday, January 2, 2013

ISCO has slipped to near an historic support level at 15 cents. This video takes a look at a 5-year weekly chart to identify the support and briefly discuss a “meeting line” pattern from the last two candles that puts the chart on radar for a potential move upward. To view the video chart, visit the following link: http://www.qualitystocks.net/videocharts Let us hear your thoughts below:

WednesdayJan 02, 2013 10:44 am

SORL Auto Parts, Inc. (SORL) Receives High-Tech Enterprise Status and Preferred Tax Rate

SORL Auto Parts, a leading supplier of brake and control systems to the global commercial vehicle industry, recently announced that the Chinese government renewed its status as a High-Tech Enterprise. SORL will receive a preferred tax rate of 15% for three fiscal years, compared with the normal 25% corporate tax rate. Qualifications include: • Own proprietary intellectual rights • Operate in a government-selected industry • R&D expenditures and income from high-tech products/services each must meet a required minimum percentage of annual revenue • The number of R&D personnel must meet a required percentage of total employees SORL has received its…

Site Search

Company Search

Month: January 2013